Insights

Explore 4 biopharma industry trends highlighted at the 2606 MassBio State of Possible Conference and key considerations for biopharmaceutical leaders.

Explore the key trends in alternative investments observed throughout 2025 and the emerging themes that appear to be gaining momentum in 2026.

Explore how the utility sales tax exemption works for manufacturers, including how eligibility varies by state, to uncover savings opportunities.

CBP filed a declaration with the U.S. CIT on ACE system progress regarding CAPE. Learn what importers should expect for IEEPA tariff refunds.

Understand how the new excise tax on remittance transfers, introduced under the One Big Beautiful Bill Act, works and its implications for RTPs.

Tune in to our session on energy-related tax incentive updates and gain practical insights for aligning energy investments with tax and business objectives.

An amended CIT order excludes IEEPA tariff refund requirements for liquidated and finalized entries. Explore potential next steps for affected taxpayers.

Learn about Delaware Statutory Trusts (DSTs), Opportunity Zones and 1031 exchanges for real estate capital gains deferment.

Get key facts about the new USTR Section 301 investigations relating to excess manufacturing capacity and failure to enforce the ban on forced labor.

Understand how state conformity positions on federal tax changes are creating new compliance considerations for multi-state businesses in 2026.